Signature Estate & Investment Advisors LLC raised its position in Monsanto Company (NYSE:MON) by 4.0% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 138,242 shares of the basic materials company’s stock after buying an additional 5,292 shares during the period. Monsanto accounts for about 1.8% of Signature Estate & Investment Advisors LLC’s investment portfolio, making the stock its 23rd biggest position. Signature Estate & Investment Advisors LLC’s holdings in Monsanto were worth $16,564,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in shares of Monsanto by 2.6% during the second quarter. Vanguard Group Inc. now owns 30,725,725 shares of the basic materials company’s stock worth $3,636,697,000 after purchasing an additional 784,418 shares in the last quarter. BlackRock Inc. lifted its position in shares of Monsanto by 6.5% during the second quarter. BlackRock Inc. now owns 27,898,255 shares of the basic materials company’s stock worth $3,302,038,000 after purchasing an additional 1,705,439 shares in the last quarter. State Street Corp lifted its position in shares of Monsanto by 0.6% during the second quarter. State Street Corp now owns 20,276,780 shares of the basic materials company’s stock worth $2,399,965,000 after purchasing an additional 122,814 shares in the last quarter. Northern Trust Corp lifted its holdings in Monsanto by 0.7% in the second quarter. Northern Trust Corp now owns 7,092,929 shares of the basic materials company’s stock valued at $839,519,000 after buying an additional 47,725 shares during the period. Finally, Flossbach Von Storch AG lifted its holdings in Monsanto by 7.5% in the second quarter. Flossbach Von Storch AG now owns 4,397,000 shares of the basic materials company’s stock valued at $520,429,000 after buying an additional 307,600 shares during the period. Hedge funds and other institutional investors own 74.50% of the company’s stock.

In related news, CFO Pierre Courduroux sold 4,320 shares of the firm’s stock in a transaction dated Thursday, October 19th. The shares were sold at an average price of $122.00, for a total transaction of $527,040.00. Following the transaction, the chief financial officer now directly owns 48,388 shares of the company’s stock, valued at $5,903,336. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, VP Nicole M. Ringenberg sold 7,890 shares of the firm’s stock in a transaction dated Monday, October 16th. The stock was sold at an average price of $122.25, for a total transaction of $964,552.50. Following the transaction, the vice president now directly owns 38,600 shares in the company, valued at $4,718,850. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 49,236 shares of company stock worth $5,931,934. 0.79% of the stock is owned by insiders.

MON has been the topic of several analyst reports. Zacks Investment Research lowered shares of Monsanto from a “buy” rating to a “hold” rating in a report on Tuesday, September 5th. BMO Capital Markets restated a “buy” rating and issued a $128.00 price objective on shares of Monsanto in a report on Friday, September 1st. BidaskClub raised shares of Monsanto from a “sell” rating to a “hold” rating in a research note on Saturday, August 19th. Vetr downgraded shares of Monsanto from a “buy” rating to a “hold” rating and set a $122.35 target price for the company. in a research note on Wednesday, August 2nd. Finally, Barclays PLC reaffirmed an “equal weight” rating and issued a $124.00 target price (up previously from $120.00) on shares of Monsanto in a research note on Thursday, October 5th. Eleven analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $124.61.

ILLEGAL ACTIVITY NOTICE: This report was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another publication, it was copied illegally and republished in violation of US and international trademark and copyright law. The original version of this report can be viewed at https://www.thecerbatgem.com/2017/11/14/monsanto-company-mon-holdings-boosted-by-signature-estate-investment-advisors-llc.html.

Monsanto Company (NYSE:MON) traded down $0.15 during midday trading on Tuesday, hitting $118.15. 1,797,000 shares of the stock were exchanged, compared to its average volume of 1,937,191. The company has a current ratio of 1.35, a quick ratio of 0.83 and a debt-to-equity ratio of 1.12. The firm has a market cap of $52,040.00, a PE ratio of 21.39, a PEG ratio of 1.70 and a beta of 1.05. Monsanto Company has a one year low of $97.44 and a one year high of $122.79.

Monsanto (NYSE:MON) last posted its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.61. The company had revenue of $2.69 billion during the quarter, compared to analysts’ expectations of $2.51 billion. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. Monsanto’s quarterly revenue was up 4.8% compared to the same quarter last year. During the same quarter last year, the company posted $0.07 EPS. equities analysts anticipate that Monsanto Company will post 5.74 EPS for the current fiscal year.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Stock Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related stocks with our FREE daily email newsletter.